L-serine treatment in a patient with refractory epilepsy due to a GRIN2A missense mutation.

IF 2 4区医学 Q3 CLINICAL NEUROLOGY

Acta neurologica Belgica Pub Date : 2024-08-06 DOI:10.1007/s13760-024-02616-8

Hui Jin Shin, Ara Ko, Se Hee Kim, Hoon-Chul Kang, Joon Soo Lee

引用次数: 0

Abstract Image

查看原文本刊更多论文

L-丝氨酸治疗一名因GRIN2A错义突变导致的难治性癫痫患者。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Acta neurologica Belgica 医学-临床神经学

CiteScore

4.20

自引率

3.70%

发文量

300

审稿时长

6-12 weeks

期刊介绍： Peer-reviewed and published quarterly, Acta Neurologica Belgicapresents original articles in the clinical and basic neurosciences, and also reports the proceedings and the abstracts of the scientific meetings of the different partner societies. The contents include commentaries, editorials, review articles, case reports, neuro-images of interest, book reviews and letters to the editor. Acta Neurologica Belgica is the official journal of the following national societies: Belgian Neurological Society Belgian Society for Neuroscience Belgian Society of Clinical Neurophysiology Belgian Pediatric Neurology Society Belgian Study Group of Multiple Sclerosis Belgian Stroke Council Belgian Headache Society Belgian Study Group of Neuropathology